Navigation Links
Doctors Said – ‘Stop Pressurising NHS Advisory Bod’

The NICE (National Institute for Health and Clinical Excellence) carried out study regarding whether if new drugs and technologies are cost effective or not//.

But British Medical Journal doctors complained that NICE has carried out an invaluable work, which was set up by the government in 1999 for making NHS resources better.

NICE has published about 86 sets of guidance and recommendations about 117 topics. Doctors at the University of Southampton and Birmingham's City Hospital reviewed and found that recommendations were very evenly distributed as no for 19%, yes for 23%, yes with major restrictions for 32% and yes with minor restrictions for 28%.

But it was now under increasing pressure from those who seek to influence its decisions and some campaigners.

Because, some drugs were not approved legally by the trusts, for example the breast cancer drug Herceptin, led to legal challenges and refused to take into treatment.

Cancer institutes and charities have also been under critical state for the delays to get NICE approval. After getting licenced some drugs some drugs are still not been approved nearly three years -- a report says last year.

James Raftery, a professor of health technology assessment, said: It was clear that politicians seem to control NICE and companies, which have to make a profit, will seek it and also NICE had relaxed its advice on treatment for Alzheimer's disease and osteoporosis after vocal campaigns.

Although it was under pressure, it needs that NICE must ensure about the funding available for drugs in the NHS was spent in the right way, which is for patients.


'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: